We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Fertility Testing with Randox Biochips

Read time: Less than a minute
Time is of the essence in fertility testing and Randox biochips provide diagnosis of disorders associated with the reproductive system. The fertility biochip array allows simultaneous quantitative measurement of six fertility hormones from a single patient sample.

Randox fertility array analyses hormones that regulate the reproductive cycle and are used to test for various associated conditions including infertility as well as non reproductive disorders such as cancer.

The array includes estradiol which is involved in the growth of the female reproductive organs and menstruation. Estradiol is used to determine the cause of amenorrhea and to diagnose precocious puberty and gynecomastia.

Randox biochip array technology is based on ELISA principles and with as little as 75µl of serum, all six parameters can be analysed at once. Analytes include; FSH, LH, prolactin, progesterone, testosterone and estradiol.

Randox have developed the fully automated Evidence and the semi-automated Evidence Investigator systems for analysis of biochip arrays generating up to 378 fertility tests results per hour.
Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.